Inhibition of recombinant human CYP3A5 in supersomes using midazolam as substrate after 5 mins by LC-MS/MS analysis
C1=CC(=CC=C1C#N)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,33000
C1=CC(=CC(=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,11400
C1=CC(=CC(=C1)Cl)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,52000
C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,44000
C1COCCN1C(=O)C2=CC(=CC=C2)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,60000
C1=CC(=CC=C1C2=CC=C(C=C2)O)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,21000
C1=CC(=CC(=C1)[N+](=O)[O-])NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,31500
CCC1=CNC2=NC=NC(=C12)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(=O)NC(C)C,8100
C1=CC=C2C(=C1)C=CC=C2C3=CC=C(C=C3)NC(=O)NC4=CC=C(C=C4)C5=C6C(=NC=C5)N=CN6,13000
CCN(CC)C(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,8600
C1CCN(CC1)C(=O)C2=CC(=CC=C2)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,5500
CC(C)NC(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CNC4=NC=N3)Cl,44000
CC(C)NC(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=CC=NC=C3,980
C1CCC(C1)NC(=O)C2=CC(=CC=C2)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,6900
CN(C)C(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,60000
CC(C)N(C(C)C)C(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,1600
COC1=CC=CC(=C1)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=C5C(=NC=C4)N=CN5,6800
C1=CC(=CC=C1C2=C3C(=NC=C2)N=CN3)NC(=O)NC4=CC=C(C=C4)Br,60000
C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4)Cl,6100
C1=CC(=CC(=C1)Br)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,11400
CCNC(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C(=NC=C3)N=CN4,20300
CC(C)NC(=O)C1=CC(=CC=C1)NC(=O)NC2=CC=C(C=C2)C3=C4C=CNC4=NC=N3,34000
CC1=CNC2=NC=NC(=C12)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(=O)NC(C)C,60000
